Life Technologies Acquires Cancer Bioinformatics Firm Compendia | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies today announced it has acquired cancer bioinformatics firm Compendia for an undisclosed amount.

Based in Ann Arbor, Mich., Compendia develops products used by drug manufacturers for identifying novel gene targets in drug discovery and development, and according to Life Tech, its expertise in oncology and proprietary assets "enhance Life's diagnostic development capabilities across multiple platforms, including next-generation sequencing, qPCR, and proteome analysis."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.